1160682-17-6

Basic information

• Product Name: methyl 2,3-diamino-6-methoxybenzoate
• Synonyms: methyl 2,3-diamino-6-methoxybenzoate
• CAS NO: 1160682-17-6
• Molecular Weight: 196.206
• Mol File: 1160682-17-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 2,3-diamino-6-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2,3-diamino-6-methoxybenzoate(1160682-17-6)
• EPA Substance Registry System: methyl 2,3-diamino-6-methoxybenzoate(1160682-17-6)

Safety Data

• Hazardous Substances Data: 1160682-17-6(Hazardous Substances Data)

Upstream product

• 84832-01-9 methyl 2,6-difluoro-3-nitrobenzoate 
• 346691-23-4 methyl 2-amino-6-fluoro-3-nitrobenzoate 
• 13671-00-6 methyl 2,6-difluorobenzoate 

Downstream Products

• 1193789-52-4 methyl 5-(methyloxy)-2-phenyl-1H-benzimidazole-4-carboxylate 
• 1160683-50-0 6-hydroxy-2-phenyl-5-quinoxalinecarboxylic acid 
• 1160682-44-9 Methyl 6-(methyloxy)-2-(phenyloxy)-5-quinoxalinecarboxylate 
• 1160683-49-7 methyl 6-(methyloxy)-2-phenyl-5-quinoxalinecarboxylate 
• 1160682-45-0 6-Hydroxy-2-(phenyloxy)-5-quinoxalinecarboxylic acid 
• 1160682-40-5 Methyl 6-(methyloxy)-2-(phenylamino)-5-quinoxalinecarboxylate 
• 1160682-41-6 6-Hydroxy-2-(phenylamino)-5-quinoxalinecarboxylic acid 
• 1160682-37-0 6-Hydroxy-2-[(phenylmethyl)amino]-5-quinoxalinecarboxylic acid 
• 1160682-36-9 Methyl 6-(methyloxy)-2-[(phenylmethyl)amino]-5-quinoxalinecarboxylate 
• 1160682-43-8 N-{[6-hydroxy-2-(phenyloxy)-5-quinoxalinyl]carbonyl}glycine 
• 1160683-48-6 N-[(6-hydroxy-2-phenyl-5-quinoxalinyl)carbonyl]glycine 
• 1160683-51-1 ethyl N-[(6-hydroxy-2-phenyl-5-quinoxalinyl)carbonyl]glycinate 
• 1160682-39-2 N-{[6-hydroxy-2-(phenylamino)-5-quinoxalinyl]carbonyl}glycine 
• 1160684-39-8 N-({6-hydroxy-2-[4-(methyloxy)phenyl]-5-quinoxalinyl}carbonyl)glycine 

Relevant articles and documents

HETEROCYCLIC COMPOUND

Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, periphera

PROLYL HYDROXYLASE INHIBITORS

The invention described herein relates to certain benzimidazol-4-ylcarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one